Härtter, S., Sennewald, R., Nehmiz, G., & Reilly, P. (2013). Oral bioavailability of dabigatran etexilate (Pradaxa®) after co‐medication with verapamil in healthy subjects. British journal of clinical pharmacology, 75(4), 1053-1062. https://doi.org/10.1111/j.1365-2125.2012.04453.x
Chicago Style (17th ed.) CitationHärtter, Sebastian, Regina Sennewald, Gerhard Nehmiz, and Paul Reilly. "Oral Bioavailability of Dabigatran Etexilate (Pradaxa®) After Co‐medication with Verapamil in Healthy Subjects." British Journal of Clinical Pharmacology 75, no. 4 (2013): 1053-1062. https://doi.org/10.1111/j.1365-2125.2012.04453.x.
MLA (9th ed.) CitationHärtter, Sebastian, et al. "Oral Bioavailability of Dabigatran Etexilate (Pradaxa®) After Co‐medication with Verapamil in Healthy Subjects." British Journal of Clinical Pharmacology, vol. 75, no. 4, 2013, pp. 1053-1062, https://doi.org/10.1111/j.1365-2125.2012.04453.x.